Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-19-006721
Filing Date
2019-04-08
Accepted
2019-04-08 17:05:56
Documents
8
Effectiveness Date
2019-04-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A mrk-def1a4a.htm DEFA14A 27521
2 check1.jpg GRAPHIC 882
3 lmrkx1x1.jpg GRAPHIC 14630
4 s002763x2_nc1.jpg GRAPHIC 112309
5 s002763x2_nc2.jpg GRAPHIC 161641
6 s002763x2_nc3.jpg GRAPHIC 55933
7 s002763x2_nc4.jpg GRAPHIC 13745
8 uncheck1.jpg GRAPHIC 8006
  Complete submission text file 0001140361-19-006721.txt   501533
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 19737900
SIC: 2834 Pharmaceutical Preparations